MAPP BIOPHARMACEUTICAL INC has a total of 17 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are CUGENE INC, ARBELE LTD and MA HENGBIAO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Zeitlin Larry | 17 |
#2 | Wec Anna | 9 |
#3 | Chandran Kartik | 9 |
#4 | Walker Laura | 9 |
#5 | Bornholdt Zachary A | 8 |
#6 | Hiatt Andrew | 8 |
#7 | Pauly Michael | 6 |
#8 | Whaley Kevin | 6 |
#9 | Bornholdt Zachary | 1 |
Publication | Filing date | Title |
---|---|---|
US2019247501A1 | Monoclonal antibody cocktails for treatment of ebola infections | |
EP3583122A1 | Monoclonal antibodies and cocktails for treatment of ebola infections | |
WO2017192483A1 | Monoclonal antibody cocktail for treatment of ebola infections | |
CA3007815A1 | Monoclonal antibody cocktails for treatment of ebola infections | |
US2013149300A1 | MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINS |